Bristol-Myers Squibb

Sr. Therapeutic Area Specialist, Neuroscience - Zeposia, Birmingham, Alabama

Birmingham, Alabama, United States

Not SpecifiedCompensation
Mid-level (3 to 4 years), Senior (5 to 8 years)Experience Level
Full TimeJob Type
UnknownVisa
Pharmaceutical, HealthcareIndustries

Requirements

Candidates should possess a Bachelor’s degree and demonstrate at least 5 years of experience in a therapeutic area, with a preference for Neuroscience. Strong scientific knowledge and the ability to engage with Health Care Providers (HCPs) are essential, along with a commitment to promoting BMS products in a compliant manner and exceeding sales targets.

Responsibilities

The Sr. Therapeutic Area Specialist will promote approved indications of BMS products within a defined territory or region, creating demand for BMS medicines by articulating clinical and scientific rationale for use in appropriate patients. They will engage with and maintain a high level of scientific expertise in assigned products and therapeutic areas, preparing and implementing territory and account plans, utilizing tools like CE^3 to inform call plans, and providing feedback. This role involves spending 100% of time in the field with external customers, liaising with other BMS functions to deliver a higher Customer Experience, and prioritizing the safe and appropriate use of BMS products while focusing on business results and performance objectives.

Skills

Neuroscience
Scientific Knowledge
HCP Engagement
Sales Targets
CE^3
Territory Planning
Account Planning
Clinical Rationale
Scientific Expertise

Bristol-Myers Squibb

Develops and delivers biopharmaceutical medicines

About Bristol-Myers Squibb

Bristol Myers Squibb (BMS) develops and delivers medicines aimed at treating serious diseases, focusing on areas like cancer, autoimmune diseases, and heart conditions. The company conducts extensive research and development to create new drugs, which are sold after receiving regulatory approval. BMS also produces generic drugs, offering affordable alternatives that meet the same quality standards as their branded counterparts. What sets BMS apart from competitors is its dual focus on both innovative and generic medicines, enhancing access to healthcare. The company's goal is to improve patient outcomes while maintaining a commitment to sustainability and corporate responsibility.

New York City, New YorkHeadquarters
1887Year Founded
$33,706.1MTotal Funding
IPOCompany Stage
Biotechnology, HealthcareIndustries
10,001+Employees

Benefits

Flexible Work Hours
Hybrid Work Options
Professional Development Budget

Risks

Increased competition in oncology from emerging biotech firms like ArsenalBio.
BMS's lawsuit over the 340B Drug Pricing Program may lead to regulatory challenges.
Rapid AI and digital tech evolution may pose integration challenges for BMS.

Differentiation

BMS focuses on innovative cancer treatments through collaborations like ArsenalBio for T cell therapies.
The company emphasizes digital health technologies, enhancing clinical trial management and patient engagement.
BMS offers both innovative and generic medicines, increasing affordable healthcare solutions.

Upsides

BMS's partnership with Medidata enhances clinical research processes and patient outcomes.
The collaboration with AI Proteins advances novel miniprotein-based therapeutics, expanding therapeutic modalities.
BMS's global license agreement with BioArctic expands its portfolio in neurodegenerative diseases.

Land your dream remote job 3x faster with AI